Release Date: 28/11/11 09:21 Summary: Scheme Meeting Presentation Price Sensitive: No Download Document 796.96KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%